AtaiBeckley (ATAI) Cash from Operations (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Cash from Operations of 21090000.0 for Q1 2026, down 18.21% year-over-year from 25785820.31 in Q1 2025, and down 18.21% quarter-over-quarter from 17841000.0 in Q1 2025.
Analysis
AtaiBeckley (ATAI) Cash from Operations (2020 - 2026) Analysis & Trends
AtaiBeckley has reported Cash from Operations for 6 years, with the latest figure at 23261000.0 in Q3 2025.
- Quarterly Cash from Operations fell 20.27% year-over-year to 23261000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 79491000.0 (up 0.77% YoY) and the FY2024 annual result came in at 82437000.0, up 2.0% from the prior year.
- Cash from Operations for Q1 2026 stood at 21090000.0, down from 17841000.0 in the prior quarter.
- The five-year high for Cash from Operations was 17841000.0 in Q1 2025, with the low at 21090000.0 in Q1 2026.
- A 5-year average of 20498105.26 and a median of 21931000.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations sank 24086.0% in 2022, then surged 34.28% in 2023.
- Over 5 years, Cash from Operations stood at 20509000.0 in 2021, then slumped by 48.74% to 30505000.0 in 2022, then advanced by 28.01% to 21962000.0 in 2023, then declined by 10.62% to 24295000.0 in 2024, then rose by 4.26% to 23261000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 23261000.0, 14094000.0, and 17841000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -88.83 Mn |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | -23.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.27 Mn |
| Mar 31, 2026 | -21.09 Mn |
| Sep 30, 2025 | -23.26 Mn |
| Jun 30, 2025 | -14.09 Mn |
| Jun 30, 2025 | -14.09 Mn |
| Mar 31, 2025 | -17.84 Mn |
| Mar 31, 2025 | -17.84 Mn |
| Dec 31, 2024 | -24.30 Mn |
| Sep 30, 2024 | -19.34 Mn |
| Jun 30, 2024 | -16.23 Mn |
| Mar 31, 2024 | -22.57 Mn |
| Dec 31, 2023 | -21.96 Mn |
| Sep 30, 2023 | -18.43 Mn |
| Jun 30, 2023 | -22.61 Mn |
| Mar 31, 2023 | -21.11 Mn |
| Dec 31, 2022 | -30.51 Mn |
| Sep 30, 2022 | -28.05 Mn |
| Jun 30, 2022 | -21.93 Mn |
| Mar 31, 2022 | -23.99 Mn |
| Dec 31, 2021 | -20.51 Mn |